SBC Medical Group Holdings Incorporated Current Income Tax Expense (Benefit)
SBC Medical Group Holdings Incorporated (SBC) reported Current Income Tax Expense (Benefit) of $11.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated current income tax expense (benefit) for the quarter ending 2026-06-30 was $11.28M, a 5.81% increase year-over-year.
- SBC Medical Group Holdings Incorporated current income tax expense (benefit) for the quarter ending 2026-03-31 was $8.61M, a 192.67% increase year-over-year.
- SBC Medical Group Holdings Incorporated current income tax expense (benefit) for the quarter ending 2025-12-31 was $8.06M, a 31.51% decline year-over-year.
- SBC Medical Group Holdings Incorporated current income tax expense (benefit) for the quarter ending 2025-09-30 was $4.02M, a 55.83% decline year-over-year.
- SBC Medical Group Holdings Incorporated current income tax expense (benefit) for fiscal 2025 was $25.69M, a 37.61% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated current income tax expense (benefit) for fiscal 2024 was $41.18M, a 33.26% increase from fiscal 2023.
- SBC Medical Group Holdings Incorporated current income tax expense (benefit) for fiscal 2023 was $30.91M.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.28M 10-Q · filed 2026-08-13 | $19.90M 10-Q · filed 2026-08-13 | $27.96M derived: sum of 3 quarters · filed 2026-08-13 | $31.98M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $8.61M 10-Q · filed 2026-05-14 | $16.68M derived: sum of 2 quarters · filed 2026-05-14 | $20.70M derived: sum of 3 quarters · filed 2026-05-14 | $31.36M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $8.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $12.09M derived: sum of 2 quarters · filed 2026-03-27 | $22.75M derived: sum of 3 quarters · filed 2026-08-13 | $25.69M 10-K · filed 2026-03-27 |
| 2025-09-30 | $4.02M 10-Q · filed 2025-11-14 | $14.69M derived: sum of 2 quarters · filed 2026-08-13 | $17.63M 10-Q · filed 2025-11-14 | $29.40M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $10.66M 10-Q · filed 2026-08-13 | $13.61M 10-Q · filed 2026-08-13 | $25.38M derived: sum of 3 quarters · filed 2026-08-13 | $34.49M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.94M 10-Q · filed 2026-05-14 | $14.72M derived: sum of 2 quarters · filed 2026-05-14 | $23.82M derived: sum of 3 quarters · filed 2026-05-14 | $35.31M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $11.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $20.88M derived: sum of 2 quarters · filed 2026-03-27 | $32.37M derived: sum of 3 quarters · filed 2026-03-27 | $41.18M 10-K · filed 2026-03-27 |
| 2024-09-30 | $9.11M 10-Q · filed 2025-11-14 | $20.60M derived: sum of 2 quarters · filed 2025-11-14 | $29.41M 10-Q · filed 2025-11-14 | $33.25M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $11.49M 10-Q · filed 2025-08-13 | $20.30M 10-Q · filed 2025-08-13 | $24.15M derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $8.81M 10-Q · filed 2025-05-15 | $12.65M derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $30.91M 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $27.06M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |